THERAPEUTIC COMBINATION IN CASE OF BENIGN PROSTATE HYPERPLASIA.

摘要

The invention relates to a novel method for treating the symptoms of benign prostate hyperplasia. According to said method, the following substances are used simultaneously: (1) an ??-1 adrenoceptor antagonist in a controlled releasing formulation or a 5-?? reductase inhibitor, and (2) a cGMP PDE 5 inhibitor in a controlled releasing formulation or a cGMP PDE 5 inhibitor having a long half-life.